120 related articles for article (PubMed ID: 15902683)
1. Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis.
Bohana-Kashtan O; Pinna LA; Fishelson Z
Eur J Immunol; 2005 Jun; 35(6):1939-48. PubMed ID: 15902683
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells.
Paas Y; Bohana-Kashtan O; Fishelson Z
Immunopharmacology; 1999 May; 42(1-3):175-85. PubMed ID: 10408378
[TBL] [Abstract][Full Text] [Related]
3. Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells.
Paas Y; Fishelson Z
Arch Biochem Biophys; 1995 Feb; 316(2):780-8. PubMed ID: 7864634
[TBL] [Abstract][Full Text] [Related]
4. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
Morgan BP; Imagawa DK; Dankert JR; Ramm LE
J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
[TBL] [Abstract][Full Text] [Related]
5. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
Husler T; Lockert DH; Sims PJ
Biochemistry; 1996 Mar; 35(10):3263-9. PubMed ID: 8605162
[TBL] [Abstract][Full Text] [Related]
6. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
Pilzer D; Fishelson Z
Int Immunol; 2005 Sep; 17(9):1239-48. PubMed ID: 16091382
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
Deng J; Gold D; LoVerde PT; Fishelson Z
Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of early apoptotic cells to complement-mediated lysis.
Attali G; Gancz D; Fishelson Z
Eur J Immunol; 2004 Nov; 34(11):3236-45. PubMed ID: 15368275
[TBL] [Abstract][Full Text] [Related]
9. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
[TBL] [Abstract][Full Text] [Related]
11. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
[TBL] [Abstract][Full Text] [Related]
13. CK2-mediated phosphorylation of a type II regulatory subunit of cAMP-dependent protein kinase from the mollusk Mytilus galloprovincialis.
Bardales JR; Hellman U; Villamarín JA
Arch Biochem Biophys; 2007 May; 461(1):130-7. PubMed ID: 17379180
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2.
Bone DB; Robillard KR; Stolk M; Hammond JR
Mol Membr Biol; 2007; 24(4):294-303. PubMed ID: 17520485
[TBL] [Abstract][Full Text] [Related]
16. Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action.
Olsen BB; Bjørling-Poulsen M; Guerra B
Int J Biochem Cell Biol; 2007; 39(1):227-37. PubMed ID: 17018259
[TBL] [Abstract][Full Text] [Related]
17. Detection of refolding conformers of complement protein C9 during insertion into membranes.
Laine RO; Esser AF
Nature; 1989 Sep; 341(6237):63-5. PubMed ID: 2475785
[TBL] [Abstract][Full Text] [Related]
18. Resorufin: a lead for a new protein kinase CK2 inhibitor.
Sandholt IS; Olsen BB; Guerra B; Issinger OG
Anticancer Drugs; 2009 Apr; 20(4):238-48. PubMed ID: 19177021
[TBL] [Abstract][Full Text] [Related]
19. Laminin-1 is phosphorylated by ecto-protein kinases of monocytes.
Trachana V; Christophorides E; Kouzi-Koliakos K; Koliakos G
Int J Biochem Cell Biol; 2005 Feb; 37(2):478-92. PubMed ID: 15474991
[TBL] [Abstract][Full Text] [Related]
20. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
